Agenda

Return

C. 49

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	February 13, 2018

Contra

Costa

County

Subject:

Amendment to Purchase Order with Werfen USA, LLC

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 02/13/2018

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 925-370-5101
cc:	Tasha Scott Margaret Harris Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: February 13, 2018
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, an amendment to Purchase Order #F47494 with Werfen USA, LLC., to increase the payment limit by $100,000 for a new payment limit of $513,275 for purchase of the ACL TOP 500 analyzer and supplies and reagents for the clinical laboratory at the Contra Costa Regional Medical Center (CCRMC), with no change in the original term of May 1, 2013 through April 30, 2018.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I budget.

BACKGROUND:

The CCRMC Clinical Laboratory needs to upgrade the ACL TOP analyzer and also needs to purchase supplies and reagents for the analyzer. The Health Services Department uses the analyzer to perform various tests for CCRMC patients. The current analyzer was purchased back in 2006 and is now past its useful life.

CONSEQUENCE OF NEGATIVE ACTION:

If this amendment is not approved, the CCRMC Clinical Laboratory will have to continue to use the existing analyzer. This analyzer was purchased back in 2006, which puts the laboratory at risk for increased downtime due to its age. The new analyzer requires less intervention by the Clinical Laboratory Scientist.